DE10312173A1 - Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac - Google Patents

Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac Download PDF

Info

Publication number
DE10312173A1
DE10312173A1 DE2003112173 DE10312173A DE10312173A1 DE 10312173 A1 DE10312173 A1 DE 10312173A1 DE 2003112173 DE2003112173 DE 2003112173 DE 10312173 A DE10312173 A DE 10312173A DE 10312173 A1 DE10312173 A1 DE 10312173A1
Authority
DE
Germany
Prior art keywords
chewing gum
stomach
pharynx
esophagus
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2003112173
Other languages
German (de)
Inventor
Ingo Hornung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE2003112173 priority Critical patent/DE10312173A1/en
Publication of DE10312173A1 publication Critical patent/DE10312173A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The chewing gum is provided with active ingredients intended to produce a beneficial effect on the mouth cavity, pharynx, esophagus, stomach and digestive tract. An independent claim is also included for producing the proposed chewing gum. ACTIVITY : Gastrointestinal-Gen. No biological data is given. MECHANISM OF ACTION : None given.

Description

Mittel zur Behandlung von Erkrankungen des Mundraums, insbesondere des Zahnfleischs oder zur Vorbeugung solcher Erkrankungen werden nach dem Stand der Technik dort aufgetragen, wo sie wirken sollen. Das gilt grundsätzlich für den gesamten Rachenraum.Agents for the treatment of diseases of the mouth, especially the gums or for prevention such diseases are applied there according to the prior art, where they should work. This basically applies to the entire throat area.

Auch Mittel, die auf Magen oder Verdauungstrakt einwirken sollen, werden nach dem Stand der Technik eigens zu diesem Zweck eingenommen.Also means that on the stomach or digestive tract according to the state of the art Purpose.

Beides wird oft als Belästigung empfunden. Dem trägt die Erfindung damit Rechnung, dass die Mittel dem Kaugummi beigemengt und damit ohne weitere Belästigung dem Bestimmungszweck zugeführt werden.Both are often considered annoyances felt. That carries the invention so that the agent added to the chewing gum and thus without further annoyance the intended purpose become.

Claims (4)

Kaugummi, dem Wirkstoffe beigemengt sind, die auf Mundhöhle, Rachenraum, Speiseröhre, Magen, Verdauungstrakt einzuwirken bestimmt sind.Chewing gum, which contains active ingredients that on oral cavity, Pharynx, esophagus, Stomach, digestive tract are intended to act. Kaugummi nach Anspruch 1, dessen beigemengtes Mittel ein oder mehrere Vitamine enthält.Chewing gum according to claim 1, the admixed agent thereof contains one or more vitamins. Kaugummi nach Anspruch 1, dessen beigemengtes Mittel zur Vorbeugung oder Behandlung von Paradonthose bestimmt ist.Chewing gum according to claim 1, the admixed agent thereof is intended for the prevention or treatment of periodontal pants. Verfahren zur Herstellung von Kaugummi, dadurch gekennzeichnet, dass dem Kaugummi Mittel nach den Ansprüchen 1, 2 und 3 beigemengt werden.Process for the production of chewing gum, characterized in that that the chewing gum agent added according to claims 1, 2 and 3 become.
DE2003112173 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac Withdrawn DE10312173A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2003112173 DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2003112173 DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Publications (1)

Publication Number Publication Date
DE10312173A1 true DE10312173A1 (en) 2004-09-30

Family

ID=32920959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2003112173 Withdrawn DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Country Status (1)

Country Link
DE (1) DE10312173A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685965T2 (en) * 1985-01-24 1992-12-24 Advance Kk ANTICARIOGENIC OR ANTIPERIODONTITIC AGENT.
DE69003244T2 (en) * 1989-07-24 1994-01-05 Fertin A S Vejle Chewing gum with accelerated administration of active agents.
DE19615820A1 (en) * 1996-04-06 1997-10-09 Holger Specht Dental care products containing orally absorbable components
DE19802050A1 (en) * 1998-01-21 1999-07-22 Labtec Gmbh Peridontal treatment composition providing local oral release of coenzyme Q10
DE69228922T2 (en) * 1991-12-20 1999-08-26 Block Drug Co Dentin desensitizer
DE19949575A1 (en) * 1999-10-14 2001-04-19 Michael Hermann Hinz Fluoride and flavonoid combination, e.g. in chewing gum and toothpaste, for the prevention of caries and the treatment of dental disorders
DE19941221A1 (en) * 1999-08-30 2001-08-16 Joachim Steuer Chewing gum contains - in the role of additives - hydrophilic vitamins and/or mineral substances and/or trace elements
DE69704426T2 (en) * 1996-05-03 2001-11-15 Atp Avant-Garde Technologies & Products S.A. Marketing & Licensing S.A., Vacallo METHOD FOR PRODUCING MEDICAL CHEWING GUM WITH A GOOD TASTE, INCLUDING AN INCLUDING COMPOUND
DE10065413A1 (en) * 2000-12-31 2002-12-12 Brecht Hans Michael Dentifrice

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685965T2 (en) * 1985-01-24 1992-12-24 Advance Kk ANTICARIOGENIC OR ANTIPERIODONTITIC AGENT.
DE69003244T2 (en) * 1989-07-24 1994-01-05 Fertin A S Vejle Chewing gum with accelerated administration of active agents.
DE69228922T2 (en) * 1991-12-20 1999-08-26 Block Drug Co Dentin desensitizer
DE19615820A1 (en) * 1996-04-06 1997-10-09 Holger Specht Dental care products containing orally absorbable components
DE69704426T2 (en) * 1996-05-03 2001-11-15 Atp Avant-Garde Technologies & Products S.A. Marketing & Licensing S.A., Vacallo METHOD FOR PRODUCING MEDICAL CHEWING GUM WITH A GOOD TASTE, INCLUDING AN INCLUDING COMPOUND
DE19802050A1 (en) * 1998-01-21 1999-07-22 Labtec Gmbh Peridontal treatment composition providing local oral release of coenzyme Q10
DE19941221A1 (en) * 1999-08-30 2001-08-16 Joachim Steuer Chewing gum contains - in the role of additives - hydrophilic vitamins and/or mineral substances and/or trace elements
DE19949575A1 (en) * 1999-10-14 2001-04-19 Michael Hermann Hinz Fluoride and flavonoid combination, e.g. in chewing gum and toothpaste, for the prevention of caries and the treatment of dental disorders
DE10065413A1 (en) * 2000-12-31 2002-12-12 Brecht Hans Michael Dentifrice

Similar Documents

Publication Publication Date Title
Ramberg et al. The influence of gingival inflammation on de novo plaque formation
US20060018843A1 (en) Halitosis, gingivitis, and periodontitis treatment and preventative composition
HUP0105027A2 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
HUP0302683A2 (en) Nutritional modules
Pretty et al. Associated postmortem dental findings as an aid to personal identification
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
ATE249828T1 (en) USE OF ISATIN AND OXINDOL DERIVATIVES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES
HUP0204550A2 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation and process for its preparation
EP1393734A4 (en) Drugs for intestinal diseases
Yassaei et al. Abnormal oral habits in the children of war veterans
DE10312173A1 (en) Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac
Wick Oral health in the long-term care facility
HUP0301271A2 (en) Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
Kim Analysis of correlation among oral environment, oral myofunction, and oral microorganisms
Dinesh Dental Caries
Asqarovna METHODS OF PHYSIOTHERAPEUTIC TREATMENT OF PERIODONTAL DISEASES
Thoma Teeth, Diet, and Health
Ebaid et al. Salivary pH changes and biofilm formation during active orthodontic treatment with clear aligners and fixed orthodontic appliances
Benítez et al. Medical Gingival Hyperplasia and Recurrent Aphthous Stomatitis in Epileptic Patient Inform of case
MOLAR Items Of Interest.
Tailakova et al. METHODS OF TREATMENT AND PREVENTION OF DENTAL HARD TISSUES IN CHILDREN LIVING IN ECOLOGICALLY UNFAVORABLE AREAS OF THE BUKHARA REGION
DENTAL 8th
Minic et al. The condition of oral health in regular users of psychoactive substances
JP2002114677A (en) Method for treating or preventing tooth and gingiva and preventing tool
DE69427927D1 (en) Use of trimetazidine in the manufacture of medicaments for the treatment of health disorders caused by the nephrotoxicity of cyclosporin A.

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8139 Disposal/non-payment of the annual fee